Pricing Log in Create free account

Hyperion DeFi, Inc. (HYPD) vs Sangamo Therapeutics, Inc. (SGMOQ)

Hyperion DeFi, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Hyperion DeFi, Inc. and Sangamo Therapeutics, Inc. are of similar size ($41.9M and $39.8M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against −45.8%. Sangamo Therapeutics, Inc. has the higher net margin (−356.9% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 16 metrics below, Hyperion DeFi, Inc. leads on 8 and Sangamo Therapeutics, Inc. on 8.

Valuation

Metric HYPD SGMOQ Biotechnology median
P/E n/m n/m 10.60
P/S 25.50 1.24 9.40
P/B 0.35 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 7.06 n/m 0.66
EV/Sales 24.64 1.24 9.02
Earnings yield (245.63%) (345.45%) (32.88%)
Free cash flow yield (216.06%) (211.06%) (23.13%)

Profitability

Metric HYPD SGMOQ Biotechnology median
Gross margin 78.35% 100.00% 68.51%
Operating margin 314.32% (357.55%) 0.00%
Net margin (1,224.53%) (356.89%) 0.00%
Free cash flow margin (5,509.35%) (261.76%) 0.00%
Return on equity (24.63%) 1,755.72% (51.96%)
Return on assets (20.32%) (168.79%) (46.06%)
Return on invested capital 2.73% 0.00% 0.00%

Growth

Metric HYPD SGMOQ Biotechnology median
Revenue growth (TTM) 1,990.60% (45.80%) 6.76%
EPS growth (last fiscal year) 84.28% 10.20% 29.88%
Revenue growth, 5-year CAGR — (19.66%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYPD SGMOQ Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 2.34 0.70 4.97
Net debt to EBITDA (0.03) 0.18 1.01

Dividend

Metric HYPD SGMOQ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HYPD SGMOQ Biotechnology median
Market cap 39.78m 41.89m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack